IMMUNOMODULATORY EFFECTS OF VITAMIN D AND ITS STATUS IN PATIENTS WITH AUTOIMMUNE DISEASES
Abstract
The incidence of autoimmune diseases is increasing year by year, especially in Western societies. Many factors, both genetic and environmental, are involved, and vitamin D (vD, 25(OH)D3) deficiency is considered to be one of the key factors. However, the precise etiopathogenesis of autoimmune disorders is still not fully understood, which is also reflected in the limitation of therapeutic possibilities. Recently, there has been a growing interest in the role of vitamin D in alleviating autoimmunological processes, as vD has the ability to stimulate or inhibit virtually every stage of the immune response through its vitamin D receptor (VDR), expressed on immune cells. Innate and adaptive immune system and endothelial membrane stability. This allows us to define this vitamin as a strong immunomodulator in terms of both innate and acquired immunity. The aim of this paper is to present the pathophysiology of selected autoimmune diseases and to demonstrate the modifying properties of vitamin D on the immune system. Our review also demonstrates the scale of deficiency, both in the general population and among individuals diagnosed with autoimmune disease.
References
Illescas-Montes, R., Melguizo-Rodríguez, L., Ruiz, C., & Costela-Ruiz, V. J. (2019). Vitamin D and autoimmune diseases. Life sciences, 233, 116744. https://doi.org/10.1016/j.lfs.2019.116744
Kampman, M.T., Wilsgaard, T. & Mellgren, S.I. (2007). Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. Journal of Neurology. 254(4), 471-477. doi: https://10.1007/s00415-006-0395-5
Grant W. B. (2006). Epidemiology of disease risks in relation to vitamin D insufficiency. Progress in biophysics and molecular biology, 92(1), 65–79. https://doi.org/10.1016/j.pbiomolbio.2006.02.013
Cui, A., Zhang, T., Xiao, P., Fan, Z., Wang, H., & Zhuang, Y. (2023). Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Frontiers in nutrition, 10, 1070808. https://doi.org/10.3389/fnut.2023.1070808
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., Kovacs, C. S., Mayne, S. T., Rosen, C. J., & Shapses, S. A. (2011). The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. Journal of the American Dietetic Association, 111(4), 524–527. https://doi.org/10.1016/j.jada.2011.01.004
Cashman, K. D., Dowling, K. G., Škrabáková, Z., Gonzalez-Gross, M., Valtueña, J., De Henauw, S., Moreno, L., Damsgaard, C. T., Michaelsen, K. F., Mølgaard, C., Jorde, R., Grimnes, G., Moschonis, G., Mavrogianni, C., Manios, Y., Thamm, M., Mensink, G. B., Rabenberg, M., Busch, M. A., Cox, L., … Kiely, M. (2016). Vitamin D deficiency in Europe: pandemic?. The American journal of clinical nutrition, 103(4), 1033–1044. https://doi.org/10.3945/ajcn.115.120873
Amrein, K., Scherkl, M., Hoffmann, M., Neuwersch-Sommeregger, S., Köstenberger, M., Tmava Berisha, A., Martucci, G., Pilz, S., & Malle, O. (2020). Vitamin D deficiency 2.0: an update on the current status worldwide. European journal of clinical nutrition, 74(11), 1498–1513. https://doi.org/10.1038/s41430-020-0558-y
Valdivielso, J. M., & Fernandez, E. (2006). Vitamin D receptor polymorphisms and diseases. Clinica chimica acta; international journal of clinical chemistry, 371(1-2), 1–12. https://doi.org/10.1016/j.cca.2006.02.016
Kochupillai N. (2008). The physiology of vitamin D : current concepts. The Indian journal of medical research, 127(3), 256–262.
Bikle D. D. (2012). Vitamin D and the skin: Physiology and pathophysiology. Reviews in endocrine & metabolic disorders, 13(1), 3–19. https://doi.org/10.1007/s11154-011-9194-0
Konstantakis, C., Tselekouni, P., Kalafateli, M., & Triantos, C. (2016). Vitamin D deficiency in patients with liver cirrhosis. Annals of gastroenterology, 29(3), 297–306. https://doi.org/10.20524/aog.2016.0037
Carlberg, C., & Campbell, M. J. (2013). Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids, 78(2), 127–136. https://doi.org/10.1016/j.steroids.2012.10.019
Prietl, B., Treiber, G., Pieber, T. R., & Amrein, K. (2013). Vitamin D and immune function. Nutrients, 5(7), 2502–2521. https://doi.org/10.3390/nu5072502
Kim, D. H., Meza, C. A., Clarke, H., Kim, J. S., & Hickner, R. C. (2020). Vitamin D and Endothelial Function. Nutrients, 12(2), 575. https://doi.org/10.3390/nu12020575
Mathieu, C., & Badenhoop, K. (2005). Vitamin D and type 1 diabetes mellitus: state of the art. Trends in endocrinology and metabolism: TEM, 16(6), 261–266. https://doi.org/10.1016/j.tem.2005.06.004
Marques, C. D., Dantas, A. T., Fragoso, T. S., & Duarte, A. L. (2010). The importance of vitamin D levels in autoimmune diseases. Revista brasileira de reumatologia, 50(1), 67–80.
Di Rosa, M., Malaguarnera, M., Nicoletti, F., & Malaguarnera, L. (2011). Vitamin D3: a helpful immuno-modulator. Immunology, 134(2), 123–139. https://doi.org/10.1111/j.1365-2567.2011.03482.x
Kostoglou-Athanassiou, I., Athanassiou, P., Lyraki, A., Raftakis, I., & Antoniadis, C. (2012). Vitamin D and rheumatoid arthritis. Therapeutic advances in endocrinology and metabolism, 3(6), 181–187. https://doi.org/10.1177/2042018812471070
Turhanoğlu, A. D., Güler, H., Yönden, Z., Aslan, F., Mansuroglu, A., & Ozer, C. (2011). The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatology international, 31(7), 911–914. https://doi.org/10.1007/s00296-010-1393-6
Ishikawa, L. L. W., Colavite, P. M., Fraga-Silva, T. F. C., Mimura, L. A. N., França, T. G. D., Zorzella-Pezavento, S. F. G., Chiuso-Minicucci, F., Marcolino, L. D., Penitenti, M., Ikoma, M. R. V., & Sartori, A. (2017). Vitamin D Deficiency and Rheumatoid Arthritis. Clinical reviews in allergy & immunology, 52(3), 373–388. https://doi.org/10.1007/s12016-016-8577-0
Cutolo, M., Otsa, K., Uprus, M., Paolino, S., & Seriolo, B. (2007). Vitamin D in rheumatoid arthritis. Autoimmunity reviews, 7(1), 59–64. https://doi.org/10.1016/j.autrev.2007.07.001
Hewison M. (2012). Vitamin D and immune function: autocrine, paracrine or endocrine?. Scandinavian journal of clinical and laboratory investigation. Supplementum, 243, 92–102. https://doi.org/10.3109/00365513.2012.682862
Lutzky, V., Hannawi, S., & Thomas, R. (2007). Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis research & therapy, 9(4), 219. https://doi.org/10.1186/ar2200
Bhalla, A. K., Amento, E. P., Clemens, T. L., Holick, M. F., & Krane, S. M. (1983). Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. The Journal of clinical endocrinology and metabolism, 57(6), 1308–1310. https://doi.org/10.1210/jcem-57-6-1308
Harrison, S. R., Li, D., Jeffery, L. E., Raza, K., & Hewison, M. (2020). Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. Calcified tissue international, 106(1), 58–75. https://doi.org/10.1007/s00223-019-00577-2
Kinne, R. W., Stuhlmüller, B., & Burmester, G. R. (2007). Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis research & therapy, 9(6), 224. https://doi.org/10.1186/ar2333
Brzustewicz, E., & Bryl, E. (2015). The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine, 76(2), 527–536. https://doi.org/10.1016/j.cyto.2015.08.260
Neve, A., Corrado, A., & Cantatore, F. P. (2014). Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clinical and experimental medicine, 14(3), 275–283. https://doi.org/10.1007/s10238-013-0249-2
Martinez-Gamboa, L., Brezinschek, H. P., Burmester, G. R., & Dörner, T. (2006). Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmunity reviews, 5(7), 437–442. https://doi.org/10.1016/j.autrev.2006.02.004
Meena, N., Singh Chawla, S. P., Garg, R., Batta, A., & Kaur, S. (2018). Assessment of Vitamin D in Rheumatoid Arthritis and Its Correlation with Disease Activity. Journal of natural science, biology, and medicine, 9(1), 54–58. https://doi.org/10.4103/jnsbm.JNSBM_128_17
Sharma, R., Saigal, R., Goyal, L., Mital, P., Yadav, R. N., Meena, P. D., & Agrawal, A. (2014). Estimation of vitamin D levels in rheumatoid arthritis patients and its correlation with the disease activity. The Journal of the Association of Physicians of India, 62(8), 678–681.
Cen, X., Liu, Y., Yin, G., Yang, M., & Xie, Q. (2015). Association between Serum 25-Hydroxyvitamin D Level and Rheumatoid Arthritis. BioMed research international, 2015, 913804. https://doi.org/10.1155/2015/913804
Salesi, M., & Farajzadegan, Z. (2012). Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatology international, 32(7), 2129–2133. https://doi.org/10.1007/s00296-011-1944-5
Didier, K., Bolko, L., Giusti, D., Toquet, S., Robbins, A., Antonicelli, F., & Servettaz, A. (2018). Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?. Frontiers in immunology, 9, 541. https://doi.org/10.3389/fimmu.2018.00541
Ameer, M. A., Chaudhry, H., Mushtaq, J., Khan, O. S., Babar, M., Hashim, T., Zeb, S., Tariq, M. A., Patlolla, S. R., Ali, J., Hashim, S. N., & Hashim, S. (2022). An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus, 14(10), e30330. https://doi.org/10.7759/cureus.30330
Woo, J. M. P., Parks, C. G., Jacobsen, S., Costenbader, K. H., & Bernatsky, S. (2022). The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous. Journal of internal medicine, 291(6), 755–778. https://doi.org/10.1111/joim.13448
Mao, S., & Huang, S. (2014). Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis. Rheumatology international, 34(3), 381–388. https://doi.org/10.1007/s00296-013-2898-6
Chen, S., Hu, D., Shi, X., Shen, N., Gu, Y., & Bao, C. (2000). The relationship between Th1/Th2-type cells and disease activity in patients with systemic lupus erythematosus. Chinese medical journal, 113(10), 877–880.
Horwitz, D. A., Gray, J. D., Behrendsen, S. C., Kubin, M., Rengaraju, M., Ohtsuka, K., & Trinchieri, G. (1998). Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis and rheumatism, 41(5), 838–844. https://doi.org/10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S
Mok, C. C., Birmingham, D. J., Leung, H. W., Hebert, L. A., Song, H., & Rovin, B. H. (2012). Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford, England), 51(4), 644–652. https://doi.org/10.1093/rheumatology/ker212
Bonakdar, Z. S., Jahanshahifar, L., Jahanshahifar, F., & Gholamrezaei, A. (2011). Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus, 20(11), 1155–1160. https://doi.org/10.1177/0961203311405703
Smyk, D. S., Orfanidou, T., Invernizzi, P., Bogdanos, D. P., & Lenzi, M. (2013). Vitamin D in autoimmune liver disease. Clinics and research in hepatology and gastroenterology, 37(5), 535–545. https://doi.org/10.1016/j.clinre.2013.05.016
Vogel, A., Strassburg, C. P., & Manns, M. P. (2002). Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology (Baltimore, Md.), 35(1), 126–131. https://doi.org/10.1053/jhep.2002.30084
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441(7090), 235–238. https://doi.org/10.1038/nature04753
Czaja, A. J., & Montano-Loza, A. J. (2019). Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis. Digestive diseases and sciences, 64(2), 324–344. https://doi.org/10.1007/s10620-018-5351-6
Sîrbe, C., Rednic, S., Grama, A., & Pop, T. L. (2022). An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases. International journal of molecular sciences, 23(17), 9784. https://doi.org/10.3390/ijms23179784
Miroliaee, A., Nasiri-Toosi, M., Khalilzadeh, O., Esteghamati, A., Abdollahi, A., & Mazloumi, M. (2010). Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatology international, 4(3), 634–640. https://doi.org/10.1007/s12072-010-9194-2
Efe, C., Kav, T., Aydin, C., Cengiz, M., Imga, N. N., Purnak, T., Smyk, D. S., Torgutalp, M., Turhan, T., Ozenirler, S., Ozaslan, E., & Bogdanos, D. P. (2014). Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Digestive diseases and sciences, 59(12), 3035–3042. https://doi.org/10.1007/s10620-014-3267-3
Ravaioli, F., Pivetti, A., Di Marco, L., Chrysanthi, C., Frassanito, G., Pambianco, M., Sicuro, C., Gualandi, N., Guasconi, T., Pecchini, M., & Colecchia, A. (2022). Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease. International journal of molecular sciences, 23(16), 9016. https://doi.org/10.3390/ijms23169016
Svoren, B. M., Volkening, L. K., Wood, J. R., & Laffel, L. M. (2009). Significant vitamin D deficiency in youth with type 1 diabetes mellitus. The Journal of pediatrics, 154(1), 132–134. https://doi.org/10.1016/j.jpeds.2008.07.015
Paschou, S. A., Papadopoulou-Marketou, N., Chrousos, G. P., & Kanaka-Gantenbein, C. (2018). On type 1 diabetes mellitus pathogenesis. Endocrine connections, 7(1), R38–R46. https://doi.org/10.1530/EC-17-0347
Mathieu, C., Waer, M., Laureys, J., Rutgeerts, O., & Bouillon, R. (1994). Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia, 37(6), 552–558. https://doi.org/10.1007/BF00403372
Harris S. S. (2005). Vitamin D in type 1 diabetes prevention. The Journal of nutrition, 135(2), 323–325. https://doi.org/10.1093/jn/135.2.323
Wenzlau, J. M., & Hutton, J. C. (2013). Novel diabetes autoantibodies and prediction of type 1 diabetes. Current diabetes reports, 13(5), 608–615. https://doi.org/10.1007/s11892-013-0405-9
Pittas, A. G., & Dawson-Hughes, B. (2010). Vitamin D and diabetes. The Journal of steroid biochemistry and molecular biology, 121(1-2), 425–429. https://doi.org/10.1016/j.jsbmb.2010.03.042
Giulietti, A., Gysemans, C., Stoffels, K., van Etten, E., Decallonne, B., Overbergh, L., Bouillon, R., & Mathieu, C. (2004). Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia, 47(3), 451–462. https://doi.org/10.1007/s00125-004-1329-3
Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. (1999). Diabetologia, 42(1), 51–54. https://doi.org/10.1007/s001250051112
Leray, E., Moreau, T., Fromont, A., & Edan, G. (2016). Epidemiology of multiple sclerosis. Revue neurologique, 172(1), 3–13. https://doi.org/10.1016/j.neurol.2015.10.006
Tarlinton, R. E., Martynova, E., Rizvanov, A. A., Khaiboullina, S., & Verma, S. (2020). Role of Viruses in the Pathogenesis of Multiple Sclerosis. Viruses, 12(6), 643. https://doi.org/10.3390/v12060643
Arneth B. (2020). Multiple Sclerosis and Smoking. The American journal of medicine, 133(7), 783–788. https://doi.org/10.1016/j.amjmed.2020.03.008
Simpson, S., Jr, Blizzard, L., Otahal, P., Van der Mei, I., & Taylor, B. (2011). Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. Journal of neurology, neurosurgery, and psychiatry, 82(10), 1132–1141. https://doi.org/10.1136/jnnp.2011.240432
Ghasemi, N., Razavi, S., & Nikzad, E. (2017). Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell journal, 19(1), 1–10. https://doi.org/10.22074/cellj.2016.4867
Lassmann, H., Brück, W., & Lucchinetti, C. (2001). Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends in molecular medicine, 7(3), 115–121. https://doi.org/10.1016/s1471-4914(00)01909-2
Bar-Or, A., Oliveira, E. M., Anderson, D. E., & Hafler, D. A. (1999). Molecular pathogenesis of multiple sclerosis. Journal of neuroimmunology, 100(1-2), 252–259. https://doi.org/10.1016/s0165-5728(99)00193-9
Navikas, V., & Link, H. (1996). Review: cytokines and the pathogenesis of multiple sclerosis. Journal of neuroscience research, 45(4), 322–333. https://doi.org/10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B
Pröbstel, A. K., Sanderson, N. S., & Derfuss, T. (2015). B Cells and Autoantibodies in Multiple Sclerosis. International journal of molecular sciences, 16(7), 16576–16592. https://doi.org/10.3390/ijms160716576
Milajerdi, A., Maghbooli, Z., Mohammadi, F., Hosseini, B., & Mirzaei, K. (2018). Progranulin concentration in relation to bone mineral density among obese individuals. Archives of endocrinology and metabolism, 62(2), 179–186. https://doi.org/10.20945/2359-3997000000022
Hayes C. E. (2000). Vitamin D: a natural inhibitor of multiple sclerosis. The Proceedings of the Nutrition Society, 59(4), 531–535. https://doi.org/10.1017/s0029665100000768
Sioka, C., Papakonstantinou, S., Markoula, S., Gkartziou, F., Georgiou, A., Georgiou, I., Pelidou, S. H., Kyritsis, A. P., & Fotopoulos, A. (2011). Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. Journal of negative results in biomedicine, 10, 3. https://doi.org/10.1186/1477-5751-10-3
Coskun Benlidayi, I., Basaran, S., Evlice, A., Erdem, M., & Demirkiran, M. (2015). Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis. Acta clinica Belgica, 70(3), 188–192. https://doi.org/10.1179/2295333715Y.0000000002
Moen, S. M., Celius, E. G., Sandvik, L., Brustad, M., Nordsletten, L., Eriksen, E. F., & Holmøy, T. (2012). Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study. PloS one, 7(9), e45703. https://doi.org/10.1371/journal.pone.0045703
Ozgocmen, S., Bulut, S., Ilhan, N., Gulkesen, A., Ardicoglu, O., & Ozkan, Y. (2005). Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. Journal of bone and mineral metabolism, 23(4), 309–313. https://doi.org/10.1007/s00774-005-0604-9
Correale, J., Ysrraelit, M. C., & Gaitán, M. I. (2009). Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain : a journal of neurology, 132(Pt 5), 1146–1160. https://doi.org/10.1093/brain/awp033
Murphy, O., Zandi, M. S., Lindenberg, N., Murphy, E., & Chataway, J. (2016). Bone health in patients with multiple sclerosis relapses. Multiple sclerosis and related disorders, 6, 75–80. https://doi.org/10.1016/j.msard.2016.02.003
Barnes, M. S., Bonham, M. P., Robson, P. J., Strain, J. J., Lowe-Strong, A. S., Eaton-Evans, J., Ginty, F., & Wallace, J. M. (2007). Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers. Multiple sclerosis (Houndmills, Basingstoke, England), 13(5), 670–672. https://doi.org/10.1177/1352458506072666
Pierrot-Deseilligny, C., & Souberbielle, J. C. (2017). Vitamin D and multiple sclerosis: An update. Multiple sclerosis and related disorders, 14, 35–45. https://doi.org/10.1016/j.msard.2017.03.014
Kubicka-Baczyk, K., Labuz-Roszak, B., Pierzchala, K., Adamczyk-Sowa, M., & Machowska-Majchrzak, A. (2015). Calcium-phosphate metabolism in patients with multiple sclerosis. Journal of endocrinological investigation, 38(6), 635–642. https://doi.org/10.1007/s40618-014-0235-x
Kępczyńska, K., Zajda, M., Lewandowski, Z., Przedlacki, J., & Zakrzewska-Pniewska, B. (2016). Bone metabolism and vitamin D status in patients with multiple sclerosis. Neurologia i neurochirurgia polska, 50(4), 251–257. https://doi.org/10.1016/j.pjnns.2016.04.010
Niedziela, N., Pierzchała, K., Zalejska-Fiolka, J., Niedziela, J. T., Romuk, E., Torbus-Paluszczak, M., & Adamczyk-Sowa, M. (2018). Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D3. BioMed research international, 2018, 9329123. https://doi.org/10.1155/2018/9329123
Kirbas, A., Kirbas, S., Anlar, O., Turkyilmaz, A. K., Cure, M. C., & Efe, H. (2013). Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis. Acta neurologica Belgica, 113(1), 43–47. https://doi.org/10.1007/s13760-012-0123-0
Nieves, J., Cosman, F., Herbert, J., Shen, V., & Lindsay, R. (1994). High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology, 44(9), 1687–1692. https://doi.org/10.1212/wnl.44.9.1687
Fletcher, J., Cooper, S. C., Ghosh, S., & Hewison, M. (2019). The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management. Nutrients, 11(5), 1019. https://doi.org/10.3390/nu11051019
Fletcher J. (2016). Vitamin D deficiency in patients with inflammatory bowel disease. British journal of nursing (Mark Allen Publishing), 25(15), 846–851. https://doi.org/10.12968/bjon.2016.25.15.846
Ananthakrishnan, A. N., Khalili, H., Higuchi, L. M., Bao, Y., Korzenik, J. R., Giovannucci, E. L., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012). Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology, 142(3), 482–489. https://doi.org/10.1053/j.gastro.2011.11.040
Hanley, D. A., Cranney, A., Jones, G., Whiting, S. J., Leslie, W. D., Cole, D. E., Atkinson, S. A., Josse, R. G., Feldman, S., Kline, G. A., Rosen, C., & Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada (2010). Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 182(12), E610–E618. https://doi.org/10.1503/cmaj.080663
Copyright (c) 2026 Karolina Osińska, Marcin Schulz, Agnieszka Morawa, Dawid Studziński, Anna Kołcz, Michał Kulczak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
